Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tetrahydrobiopterin activates brown adipose tissue and regulates systemic energy metabolism
Yasuo Oguri, … , Hiroyuki Hasegawa, Nobuya Inagaki
Yasuo Oguri, … , Hiroyuki Hasegawa, Nobuya Inagaki
Published May 4, 2017
Citation Information: JCI Insight. 2017;2(9):e91981. https://doi.org/10.1172/jci.insight.91981.
View: Text | PDF
Research Article Metabolism

Tetrahydrobiopterin activates brown adipose tissue and regulates systemic energy metabolism

  • Text
  • PDF
Abstract

Brown adipose tissue (BAT) is a central organ that acts to increase energy expenditure; its regulatory factors could be clinically useful in the treatment of obesity. Tetrahydrobiopterin (BH4) is an essential cofactor of tyrosine hydroxylase and nitric oxide synthase (NOS). Although BH4 regulates the known regulatory factors of BAT, such as noradrenaline (NA) and NO, participation of BH4 in BAT function remains unclear. In the present study, we investigate the role of BH4 in the regulation of BAT. Hph-1 mice, a mouse model of BH4 deficiency, exhibit obesity, adiposity, glucose intolerance, insulin resistance, and impaired BAT function. Impaired BAT function was ameliorated together with systemic metabolic disturbances by BAT transplantation from BH4-sufficient mice (control mice) into BH4-deficient mice, strongly suggesting that BH4-induced BAT has a critical role in the regulation of systemic energy metabolism. Both NA derived from the sympathetic nerve and NO derived from endothelial NOS in the blood vessels participate in the regulation of BH4. In addition, a direct effect of BH4 in the stimulation of brown adipocytes via NO is implicated. Taken together, BH4 activates BAT and regulates systemic energy metabolism; this suggests an approach for metabolic disorders, such as obesity and diabetes.

Authors

Yasuo Oguri, Yoshihito Fujita, Abulizi Abudukadier, Akiko Ohashi, Tsuyoshi Goto, Futoshi Furuya, Akio Obara, Toru Fukushima, Naomi Matsuo, Minji Kim, Masaya Hosokawa, Teruo Kawada, Hiroyuki Hasegawa, Nobuya Inagaki

×

Figure 3

Impairment of BAT occurred in BH4-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Impairment of BAT occurred in BH4-deficient mice.
Changes of rectal temp...
Changes of rectal temperature in 4°C cold tolerance test (A; n = 7–8), H&E staining and white adipose cell size of brown adipose tissue (BAT) (B; n = 3) (original magnification, ×15), mitochondrial morphology in BAT by electron microscopy (C) (original magnification, ×5,000 [top], ×15,000 [bottom]; scale bar: 500 nm), mRNA levels by quantitative RT-PCR (D; n = 6–7), and protein expression levels of UCP1 (E; n = 3) in BAT of hph-1 mice and control mice of the same background at 6 weeks of age under control fat diet. Values are mean ± SEM. Statistical analysis was performed by 2-way ANOVA with Bonferroni post-hoc test (A) or Student’s t test (B, D, and E). *P < 0.05, **P < 0.01 vs. control group.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts